|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net revenues | ||||
| Cost of revenues | ||||
| Gross Profit | ||||
| Operating expenses: | ||||
| Sales and marketing expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Other operating income, net | ||||
| Total operating expenses | ||||
| (Loss) income from operations | ||||
| Interest income | ||||
| Interest expenses | ||||
| Foreign exchange (loss) gain, net | ||||
| Other income (loss), net | ||||
| Net (loss) income before income tax and share of loss in equity method investments | ||||
| Income tax expense | ||||
| Share of loss in equity method investment | ||||
| Net (loss) income | ||||
| Deemed dividend | ||||
| Other comprehensive income (loss), net of tax of nil: | ||||
| Foreign currency translation adjustments | ||||
| Comprehensive (loss) income | ||||
| Net (loss) income attributable to ordinary shareholders of the Company | ||||
| Net (loss) earnings per share: | ||||
| Basic (amounts per share) | ||||
| Diluted (amounts per share) | ||||
| Weighted average shares used in calculating net (loss) earnings per share: | ||||
| Basic (in shares) | ||||
| Diluted (in shares) |
Loading...